Literature DB >> 1675792

Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris.

A R Ahmed1, R Wagner, K Khatri, G Notani, Z Awdeh, C A Alper, E J Yunis.   

Abstract

Previous studies demonstrated that HLA-DR4 was markedly increased among Ashkenazi Jewish patients with pemphigus vulgaris (PV), almost entirely as the common Jewish extended haplotype [HLA-B38, SC21, DR4, DQw8] or as the haplotype HLA-B35, SC31, DR4, DQw8, and that HLA-DR4, DQw8 was distributed among patients in a manner consistent with dominant expression of a class II (D-region or D-region-linked) susceptibility gene. In the present study of major histocompatibility complex (MHC) haplotypes in 25 non-Jewish PV patients, DR4, DQw8 was found in 12 of the patients and DRw6, DQw5 was found in 15. Only 3 patients had neither. Only 1 of the DR4, DQw8 haplotypes was [HLA-B38, SC21, DR4, DQw8] and 2 were HLA-B35, SC31, DR4, DQw8; most were the presumed fragments (SC31, DR4, DQw8) or (SC21, DR4, DQw8) or DR4, DQw8 with some other complotype. Of the patients with DRw6, DQw5, all were DRw14, DQw5, and 6 had a rare Caucasian haplotype, HLA-Bw55, SB45, DRw14, DQw5. Four of 6 of these were found in patients of Italian extraction, as was the 1 normal example. The non-Jewish patients were of more Southern European extraction than our controls. This suggests that there are two major MHC susceptibility alleles in American patients with PV. The more ancient apparently arose on a haplotype in the Jews, HLA-B38(35), SC21(SC31), DR4, DQw8, and spread to other populations largely as D-region segments. The other arose in or near Italy on the haplotype HLA-Bw55, SB45, DRw14, DQw5 and has also partially fragmented so that many patients carry only DRw14, DQw5. The available data do not permit the specific localization of either the DR4, DQw8- or the DRw14, DQw5-linked susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675792      PMCID: PMC51806          DOI: 10.1073/pnas.88.11.5056

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  HLA class II allelic variation and susceptibility to pemphigus vulgaris.

Authors:  S J Scharf; A Friedmann; C Brautbar; F Szafer; L Steinman; G Horn; U Gyllensten; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patients.

Authors:  A R Ahmed; E J Yunis; C A Alper
Journal:  Hum Immunol       Date:  1990-04       Impact factor: 2.850

Review 3.  Pemphigus.

Authors:  N Korman
Journal:  J Am Acad Dermatol       Date:  1988-06       Impact factor: 11.527

4.  HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.

Authors:  B Carlsson; J Wallin; J Böhme; E Möller
Journal:  Hum Immunol       Date:  1987-10       Impact factor: 2.850

5.  Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.

Authors:  F Szafer; C Brautbar; E Tzfoni; G Frankel; L Sherman; I Cohen; S Hacham-Zadeh; W Aberer; G Tappeiner; K Holubar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Serum complement 'supergenes' of the major histocompatibility complex in man (complotypes).

Authors:  C A Alper; D Raum; S Karp; Z L Awdeh; E J Yunis
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

7.  Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.

Authors:  A R Ahmed; E J Yunis; K Khatri; R Wagner; G Notani; Z Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  A newly characterized HLA DQ beta allele associated with pemphigus vulgaris.

Authors:  A A Sinha; C Brautbar; F Szafer; A Friedmann; E Tzfoni; J A Todd; L Steinman; H O McDevitt
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

Review 9.  Genetic complexity and expression of human class II histocompatibility antigens.

Authors:  A J Korman; J M Boss; T Spies; R Sorrentino; K Okada; J L Strominger
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 10.983

10.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  27 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

4.  Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.

Authors:  M S Lin; S J Swartz; A Lopez; X Ding; M A Fernandez-Vina; P Stastny; J A Fairley; L A Diaz
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 5.  Setting the target for pemphigus vulgaris therapy.

Authors:  Christoph T Ellebrecht; Aimee S Payne
Journal:  JCI Insight       Date:  2017-03-09

6.  A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid.

Authors:  J C Delgado; D Turbay; E J Yunis; J J Yunis; E D Morton; K Bhol; R Norman; C A Alper; R A Good; R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris.

Authors:  Sheida Shams; Ali Akbar Amirzargar; Maryam Yousefi; Nima Rezaei; Ghasem Solgi; Farideh Khosravi; Bita Ansaripour; Batoul Moradi; Behrouz Nikbin
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

Review 8.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

9.  Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid.

Authors:  A R Ahmed; S Foster; M Zaltas; G Notani; Z Awdeh; C A Alper; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.

Authors:  K Bhol; K Natarajan; N Nagarwalla; A Mohimen; V Aoki; A R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.